The office of Novartis near Basel, Switzerland. Reuters
Eleven pharma companies led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing sector since 2018, according to a Reuters analysis, in a drive to better control production of the world’s priciest medicines.
Swiss drugmaker Novartis on won US approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, and priced the one-time treatment at a record $2.125 million. The Food and Drug Administration approved Zolgensma for children
The Department of Health-Abu Dhabi decided to withdraw 20 batches medical products used in catheterisation and other healthcare operations from the Emirate because of their possibility of causing serious infection to patients if they were not immediately substituted with good ones.
Despite strong legislations, India still grapples with the malaise of counterfeit medicines being sold in the open market and online. In fact I recently came across a report which said that about 20 per cent of the drugs manufactured in India are adulterated. It is an unhealthy prognosis but apart from that India
Abu Dhabi Developmental Holding Company (ADDH) announced on Thursday that it has reached an agreement in principle for the establishment of a local airline in Abu Dhabi in partnership
Saudi Aramco hit the $2 trillion target sought by Saudi Crown Prince Mohammed Bin Salman on Thursday as its shares racked up a second day of gains.
The Dubai Chamber of Commerce and Industry (DCCI) hosted a seminar at its headquarters earlier today which identified key economic trends expected to reshape the global economy and trade landscape in 2020,